Centre Jean Perrin

This study aims to understand why some ovarian cancer patients respond well to platinum-based chemotherapy for years, while others do not respond at all. Researchers will compare the genetics, biology, and medical history of 55 patients from two groups: those whose cancer worsene…

This study looks at whether a simple blood test can find leftover cancer cells in people treated for advanced head and neck cancer. About 59 participants will give blood samples one and three months after finishing chemoradiotherapy. Researchers will compare the blood test result…

This study looks for new genes that might cause a hereditary risk for uveal melanoma, a rare eye cancer. Only 20% of family-linked cases are explained by known genes, so researchers will analyze DNA from 50 patients to find unknown ones. The goal is to improve screening and surve…

This study takes tumor samples from women with aggressive breast cancers (triple-negative or luminal B) and transplants them into mice to grow. The goal is to better understand how tumors change, resist treatment, and spread. About 85 participants will provide samples, but this r…

This study tests whether augmented reality (AR) can help surgeons locate small breast tumors that can't be felt. Normally, doctors insert a metal wire into the breast before surgery, which can be painful and sometimes leads to repeat operations. The AR system creates a 3D overlay…

This study is looking for genetic clues in tumor tissue that could help doctors know ahead of time whether Lu-PSMA treatment will work for men with advanced, castration-resistant prostate cancer. About 120 men who have already tried other treatments will provide tumor samples for…